We are live on ! Find out more
JAGX icon

Jaguar Health

5 hedge funds and large institutions have $223K invested in Jaguar Health in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

533% more capital invested

Capital invested by funds: $35.2K → $223K (+$188K)

0.11% more ownership

Funds ownership: 0.03%0.14% (+0.11%)

0% more funds holding

Funds holding: 55 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$23.8K
Name Holding Trade Value Shares
Change
Change in
Stake
DS
1
DRW Securities
Illinois
$212K +$194K +2,859 New
TRCT
2
Tower Research Capital (TRC)
New York
$7.88K +$3.79K +56 +112%
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$2K
SS
4
SBI Securities
Japan
$513 +$68 +1 +17%
LSA
5
Leonteq Securities AG
Switzerland
$438
Bank of America
6
Bank of America
North Carolina
$33
Morgan Stanley
7
Morgan Stanley
New York
$23
BlackRock
8
BlackRock
New York
$9
UBS Group
9
UBS Group
Switzerland
$2 -$23.8K -351 Closed

JAGX Hedge Fund Activity: Q3 2025 in Review

5 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q3 2025, worth a combined $223K — up 533% from $35.2K a quarter earlier.

Fund positioning in JAGX was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was DRW Securities, opening a new position worth an estimated $194K. The largest seller was UBS Group, exiting entirely with an estimated $23.8K sold.

  • 5 institutional investors held Jaguar Health (JAGX) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $223K of Jaguar Health stock for Q3 2025, up 533% quarter-over-quarter.
  • 1 fund opened new Jaguar Health positions in Q3 2025 and 1 closed out, a net change of 0 holders.
  • The largest Jaguar Health buyer in Q3 2025 was DRW Securities, an estimated $194K added.
  • The largest Jaguar Health seller in Q3 2025 was UBS Group, an estimated $23.8K sold.

Based on aggregated 13F filings for Q3 2025.